COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Données clés pour la 17ème augmentation de capital du Akara Swiss Diversity Property Fund PK (Akara Diversity PK) 17ème augmentation de capital du Akara Diversity PK pour une croissance durable. Période de souscription du 18 mai au 12 juin 2026. Volume d'émission de 184'879 nouvelles parts Suisse Augmentation Du Capital Swiss Prime Site Solutions Fonds Immobilier Akara Diversity PK
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026 Cantourage Group SE significantly increases profitability in the first quarter of 2026 driven by premium products and international expansion, with revenue growth and solid financial position EBITDA Margin International Expansion Cantourage Group SE Profitability Growth Premium Products
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours JDC starts in the year with a quarterly revenue of approximately EUR 75 million for the first time – EBITDA rises by more than 60 percent JDC Group AG reports record quarterly revenue of approximately EUR 75 million for Q1 2026, with EBITDA rising by over 60%. Strong financial growth despite challenging market environment Financial Performance Record Revenue EBITDA Growth JDC Group AG Q1 2026
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Eleving Group 3M results ended on March 31, 2026 Eleving Group S.A. reports a record-high revenue of EUR 77.8 million in Q1 2026, with diversified business operations and strong financial results, including a 30.4% increase in adjusted EBITDA Financial Results EBITDA Revenue Eleving Group Q1 2026
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Pentixapharm Announces IND Submission to FDA for Phase 3 PANDA Study of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic Pentixapharm submits IND to FDA for Phase 3 PANDA study of CXCR4-targeted cardiovascular diagnostic, aiming at precision diagnostics in primary aldosteronism Pentixapharm IND Submission Phase 3 PANDA Study CXCR4-targeted Cardiovascular Diagnostic
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Capital B annonce une levée de 15,2 M EUR auprès d'investisseurs institutionnels internationaux, dont les investisseurs stratégiques Adam Back et TOBAM, pour accélérer sa stratégie de Bitcoin Treasury Company Capital B annonce une levée de 15,2 M€ auprès d'investisseurs institutionnels internationaux, dont les investisseurs stratégiques Adam Back et TOBAM, pour accélérer sa stratégie de Bitcoin Treasury Company Investisseurs Institutionnels Levée De Fonds Bitcoin Treasury Company Adam Back Capital B
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 08:00, il y a 2 mois 24 jours Capital B announces a EUR 15.2 million capital raise with global institutional investors, including strategic investors Adam Back and TOBAM, to accelerate its Bitcoin Treasury Company strategy Capital B announces a €15.2 million capital raise with global institutional investors, including strategic investors Adam Back and TOBAM, to accelerate its Bitcoin Treasury Company strategy. Details on private placement, warrants, and accelerated exercise period provided Private Placement Warrants Bitcoin Treasury Company Capital B €15.2 Million
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 07:45, il y a 2 mois 24 jours Stabilus sharpens its profile with sale of Fabreeka and Tech Products to VMC Group Stabilus sharpens profile by selling Fabreeka and Tech Products to VMC Group for USD 92 million. Focus on core business. No impact on FY2026 guidance Sale Tech Products Stabilus Fabreeka VMC Group
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 07:36, il y a 2 mois 24 jours LR Health & Beauty SE publishes results for first quarter of 2026 LR Health & Beauty SE reports Q1 2026 sales of EUR 60.8 million with EBITDA of EUR 5.2 million. Focus on strategic initiatives for positive business development. Successful product launch at LR Business Days EBITDA Strategic Initiatives Product Launch LR Health & Beauty SE Q1 2026 Sales
COMMUNIQUÉ DE PRESSE publié le 11/05/2026 à 07:30, il y a 2 mois 24 jours adesso SE increases sales by 13% to EUR 398.1 million in the first quarter of 2026 / EBITDA of EUR 27.0 million is in line with expectations and significantly higher than previous year (EUR 17.1 m) adesso SE reports 13% sales growth in Q1 2026, reaching EUR 398.1 million, with EBITDA of EUR 27.0 million. Positive outlook despite challenges in the macroeconomic environment EBITDA Sales Growth Macroeconomic Environment Adesso SE Q1 2026
Publié le 04/08/2026 à 18:32, il y a 1 heure 46 minutes Total number of voting rights and shares making up the share capital at July 31, 2026
Publié le 04/08/2026 à 17:45, il y a 2 heures 34 minutes INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 04/08/2026 à 17:00, il y a 3 heures 19 minutes Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
Publié le 04/08/2026 à 16:25, il y a 3 heures 54 minutes ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Publié le 04/08/2026 à 15:00, il y a 5 heures 19 minutes Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Publié le 04/08/2026 à 15:00, il y a 5 heures 19 minutes Secure Blockchain's Agentic Solutions Signs First Enterprise AI Customer
Publié le 04/08/2026 à 14:30, il y a 5 heures 49 minutes Agassi Sports Entertainment Launches Global "Let's Play" Pickleball and Padel Platform Initiative
Publié le 04/08/2026 à 20:05, il y a 13 minutes Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Publié le 04/08/2026 à 19:39, il y a 39 minutes EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again
Publié le 04/08/2026 à 18:25, il y a 1 heure 53 minutes Amendment to the Prospectus of the Company and the Key Information Documents of the SubFunds